raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:35878

Hyperinsulinism-hyperammonemia syndrome

Synonyms: HI/HA syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Infancy, Neonatal
Status
active

A rare diffuse form of congenital hyperinsulinism characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), chronic hyperammonemia and recurrent episodes of hypoglycemia induced by fasting and protein rich meals. Epilepsy and cognitive deficit, which are unrelated to hypoglycemia but possibly related to the chronic hyperammonemia, may also occur. This disorder is usually responsive to diazoxide treatment.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHyperinsulinism-hyperammonemia syndromeHI/HA syndrome
frSyndrome d'hyperinsulinisme et hyperammoniémieSyndrome HI/HA
deHyperinsulinismus-Hyperammonämie-SyndromHI/HA-Syndrom
esSíndrome de hiperinsulinismo-hiperamonemiaSíndrome HI/HA
itSindrome iperinsulinismo-iperammoniemiaSindrome HI/HA
nlHyperinsulinisme - hyperammoniëmie-syndroomHI/HA-syndroom
ptSíndrome de hiperinsulinismo-hiperamoniemia
plZespół hiperinsulinizm-hiperammonemiaZespół HI/HA
csSyndrom zahrnující hyperinzulinismus a hyperamonémiiHI/HA syndrom
ukСиндром гіперінсулінізму-гіперамонієміїСиндром HI/HA
zh高胰岛素-高血氨综合征HI/HA综合征
trHiperinsülinizm-hiperammonemi sendromuHI/HA sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM606762Evalidated
ICD-10E72.8NTBTattributedvalidated
ICD-115C50.AYNTBTindexvalidated
MONDO0011717Evalidated
MeSHC538375Evalidated
UMLSC1847555Evalidated
GARD9931Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GLUD1Disease-causing germline mutation(s) inAssessedHGNC:4335ENSG0000014867213813010q23.2glutamate dehydrogenase 19571255[PMID]_20936362[PMID]_25733449[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—EuropeClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

12 annotations · validated 2019-05-23
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0008162Asymptomatic hyperammonemia
HP:0012051Reactive hypoglycemia
Frequent (79-30%)
HP:0007018Attention deficit hyperactivity disorder
HP:0011198EEG with generalized epileptiform discharges
HP:0008283Fasting hyperinsulinemia
HP:0002121Generalized non-motor (absence) seizure
HP:0002197Generalized-onset seizure
HP:0001263Global developmental delay
HP:0000825Hyperinsulinemic hypoglycemia
HP:0012402Increased urine alpha-ketoglutarate concentration
HP:0002342Intellectual disability, moderate
HP:0001328Specific learning disability

Run the differential on the 2 obligate / very frequent terms

Annotation source: 11241047[PMID]_21130127[PMID]_14967154[PMID]_20936362[PMID]_11518822[PMID]

7

Sources for this card